Homology Medicines, Inc.
(NASDAQ : FIXX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 6.84%170.810.0%$1433.85m
AMGNAmgen, Inc. 0.23%255.711.3%$690.21m
NVAXNovavax, Inc. 12.50%227.3580.0%$655.57m
SNSSSunesis Pharmaceuticals, Inc. -0.37%8.000.7%$559.23m
ILMNIllumina, Inc. -0.74%399.003.5%$519.65m
GILDGilead Sciences, Inc. 1.67%66.871.0%$470.50m
REGNRegeneron Pharmaceuticals, Inc. 1.61%502.602.7%$458.74m
VRTXVertex Pharmaceuticals, Inc. -0.77%219.391.9%$388.60m
ALXNAlexion Pharmaceuticals, Inc. 3.90%163.682.0%$348.10m
BNTXBioNTech SE 7.69%151.540.0%$313.57m
BIIBBiogen, Inc. -0.05%270.311.7%$263.29m
EXASEXACT Sciences Corp. -0.37%130.0418.4%$186.19m
NBIXNeurocrine Biosciences, Inc. 1.66%96.584.9%$179.73m
CRSPCRISPR Therapeutics AG -4.27%118.560.6%$166.57m
SGENSeagen Inc. -2.77%145.505.8%$146.84m

Company Profile

Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the design and development of treatments to address rare diseases at the genetic level. It develops genetic medicines by translating proprietary, next generation gene editing, and gene therapy technologies into novel treatments for patients with rare diseases. The company was founded by Saswati Chatterjee in 2015 and is headquartered in Bedford, MA.